Theme: Adolescent & Young Adults Oncology (AYA Oncology)
Date:  11 March, 2021 (Thu), 19:00-20:40 HKT


The Importance and Relevance of Dedicated AYA Oncology Care

Presenter: Dr. Jeremy Lewin, Medical Director, Victorian Adolescent and Young Adult Cancer Service, Peter MacCallum Cancer Centre, Melbourne, Australia

A cancer diagnosis during the adolescent and young years (AYA) can be highly challenging for young people and their families. In response to their unique clinical needs and the lagging survival improvement seen within this population, there has been an acknowledgement of the importance of dedicated supports for AYA. Key elements of AYA oncology are increasingly being described including the importance of: developmentally appropriate care; partnerships between the paediatric and adult sector; leveraging existing cancer services to meet the needs of young people; AYA multidisciplinary teams; care centralisation; promotion of clinical trials; and facilitation of transition to healthy survivorship.  This presentation will share the importance and dedicated AYA oncology care with a focus on its relevance to sarcoma programs.  It will provide an overview of AYA cancer epidemiology and outcomes, a discussion of mechanisms for sarcoma programs to serve as a template for AYA oncology more broadly and mechanisms to promote clinical trials. A detailed reflection on AYA program development in Victoria, Australia will follow, reviewing the process of program establishment as well as describing critical components of the current model of care.

Topic 2: Addressing the unique needs of AYA cancer survivors in Hong Kong: Current gaps and opportunities
Presenter: Prof. Yin-Ting Cheung, Assistant Professor, School of Pharmacy, CUHK


Major advances in health care delivery have dramatically improved the survival rates for pediatric and AYA cancer. Unfortunately, survivorship often comes at a cost of developing a myriad of treatment-related complications. In this presentation, I will first highlight the unique health and psychosocial problems that can adversely impact survivors’ quality of life and functional outcomes. I will discuss key findings of survivorship studies from both international and local collaborations. Moving beyond characterizing late effects in survivors, I will also share the current gaps and future research direction in optimizing quality survivorship care in the AYA cancer population. The eventual goal of this work is to develop an evidence-based and culturally relevant model that will facilitate “personalized survivorship care” for each cancer survivor.


Theme: Gastrointestinal Stromal Tumour (GIST)

Topic 1:The Advances in the Management of Later-line GIST-implications and applications of New Target Therapy
Speaker: Prof. Sebastian Bauer, Germany

Topic 2: Surgical advances in the management of GIST — from MIS to scarless surgery
Speaker: Prof. Shannon Melissa Chan, CUHK


Theme: Tenosynovial Giant Cell Tumour (TGCT)

Topic 1: PVNS/TGCT – When to treat and how to treat?
Speaker : Dr. Chao-Ming Chen, Taiwan

Topic 2: Practical aspects of systemic therapies in the management of PVNS/TGCT
Speaker: Dr. Tom Wei-Wu Chen, Taiwan


Theme: Interactive Multidisciplinary Case Discussions

Topic 1: Precision sarcoma care
Speaker: Dr. Jay S. Wunder, Canada

Topic 2: NTRK-fusion sarcomas – case presentation and pathological diagnosis
Speaker: Prof. Kenneth Tou En Chang, Singapore

Topic 3: Interactive Multidisciplinary Case Discussions
Speaker: TBC

Meet Our Speakers

Dr. Tom Wei-Wu CHEN

Tom Wei-Wu Chen, MD
Attending physician
Department of Oncology
National Taiwan University Hospital
Taipei, Taiwan

Dr. Tom W. Chen is currently an attending physician at the Department of Oncology, National Taiwan University Hospital (NTUH) in Taipei, Taiwan. Dr. Chen received internal medicine training followed by a fellowship course as a medical oncologist in NTUH. Afterwards, he joined Drug Development Program (DDP) in Princess Margaret Cancer Centre in Toronto, Canada as a clinical fellow to study early phase clinical trials with Dr. Lillian Siu and Dr. Phil Bedard. During his stay in Princess Margaret, he gained more experience with next-generation sequencing and precision medicine, as well as interest in sarcoma patients.